Baird Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,379
Closed -$225K 1769
2022
Q1
$225K Buy
1,379
+185
+15% +$30.2K ﹤0.01% 1715
2021
Q4
$202K Buy
1,194
+25
+2% +$4.23K ﹤0.01% 1817
2021
Q3
$221K Buy
+1,169
New +$221K ﹤0.01% 1776